Shares of weight-loss drugmakers Novo Nordisk A/S and Eli Lilly and Co. got a nice lift Monday, after a potential competitor decided to cancel development of its GLP-1 obesity drug. “We continue ...

Scholar Rock Holding Corporation's apitegromab shows promise for SMA treatment, aims for 2025 launch. Click for my updated ...

States increasingly struggling to cover the rising cost of popular GLP-1 drugs like Wegovy, Ozempic and Zepbound are ...

That was music to the ears of investors in Novo Nordisk, which makes diabetes and obesity treatments Ozempic and Wegovy; and in Eli Lilly, which makes Mounjaro and Zepbound diabetes and obesity drugs.

Chef Leah Cohen is leading the charge on Southeast Asian cuisine. Her distinct menu captures the bold, diverse flavors of Southeast Asia, inspired by her training and travels through Thailand and ...

But leading treatments like Zepbound and Novo Nordisk’s Wegovy are injectable. Drugmakers are eager to develop an easier-to-take pill version for patients who don't want to deal with needles and ...

But leading treatments like Zepbound and Novo Nordisk’s Wegovy are injectable, and drugmakers are eager to develop an easier-to-take pill version. Pfizer had announced in late 2023 that it would ...

This includes the likes of Ozempic, Mounjaro, Saxenda and Wegovy, which can sell for up to £269 a month. The drugs have proved popular with overweight Brits who want to rapidly lose weight and ...

The weather is starting to warm up again and you might be thinking about catching a wave at the beach this summer. But if you want to start surfing on dry land, we have just the place for you. SURFSET ...

Novo Nordisk’s breakneck sales growth has continued in the first quarter of this year with a 24% increase that was helped by a doubling in turnover of obesity blockbuster Wegovy. Group revenues ...